Table 3 Risk factors analysis for the composite endpoint.

From: Prognostic value of measurement of myocardial extracellular volume using dual-energy CT in heart failure with preserved ejection fraction

Variables

Univariate

Multivariate

HR (95% CI)

P value

HR (95% CI)

P value

Sex

0.65 (0.33, 1.31)

0.229

  

Age

1.03 (1.00, 1.06)

0.079

1.01(0.98,1.04)

0.491

Smoking

1.81 (0.82, 4.01)

0.145

  

Hypertension

1.51 (0.71, 3.24)

0.289

  

Diabetes

1.33 (0.67, 2.64)

0.412

  

Atrial fibrillation

1.749 (0.89, 3.44)

0.106

  

Hemoglobin

0.983 (0.96, 1.03)

0.098

0.986 (0.97, 1.01)

0.183

NT-pro BNP

2.90 (1.20, 7.00)

0.018

2.83 (1.16, 6.88)

0.022

LVEF

0.96 (0.90, 1.01)

0.135

  

ECV

1.18 (1.08, 1.30)

0.001

1.17 (1.06–1.30)

0.001

  1. CI confidence interval, NT-pro BNP N-terminal pro-B-type natriuretic peptide, LVEF left ventricular ejection fraction, ECV extracellular volume.
Back to article page